Find your path to Stephen
105 people in our graph share verified history with Stephen — schools, employers, funds. One of them is your warm intro.
Francesco De RubertisunlockedStephen: together at Medicxi (2023–2026)
×11Stephen: together at Medicxi
About
Stephen Rapecki originated the blockbuster biologic bimekizumab from discovery to approval, combining 30 years of hands-on drug discovery at Celltech/UCB with ongoing peer-reviewed immunology research and seed-stage cofounding and advising.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Experience
- MedicxiVenture Partnercurrent2023 — presentLondon, England, United Kingdom
- UCBDirector, Experimental Therapeutics2019 — 2023
- UCBHead Of Rationally Designed NBEs2018 — 2023Slough, United Kingdom
- UCBDirector Functional Screening2017 — 2023Slough, United Kingdom
- UCBSenior Group Leader2015 — 2017Slough, United Kingdom
- UCBSenior Principle Scientist2007 — 2015
- Celltech PharmaceuticalsSenior Scientist1993 — 2007Slough, United Kingdom
Skills & more
Start-up Ventures3Early Stage Investment2Immunology11Drug Discovery13Cell Culture4Pharmacology7Clinical Development2Biopharmaceuticals6Biochemistry3Biomarkers2Drug Development5Molecular Biology3
+11 more
Monoclonal AntibodiesAssay DevelopmentAntibodiesLife SciencesBiotechnologyCell BiologyR&DCellPharmaceutical IndustryELISAIn VitroFrom Stephen's professional profile.
Colleagues at Medicxi
Frequently asked questions
- Who is Stephen Rapecki?
- Stephen Rapecki originated the blockbuster biologic bimekizumab from discovery to approval, combining 30 years of hands-on drug discovery at Celltech/UCB with ongoing peer-reviewed immunology research and seed-stage cofounding and advising.
- Where does Stephen Rapecki work?
- Stephen Rapecki is Venture Partner at Medicxi.
- What does Stephen Rapecki invest in?
- Stephen Rapecki invests in Biotech, Digital Health, Healthtech, Medical Devices.
- Where did Stephen Rapecki go to school?
- Stephen Rapecki studied at Kingston University (Bachelor of Science - BS, Biomedical Sciences); Lewis Boys School.
Same school
Also attended Kingston University61
Matthew KnowlesOperating Partner at TempoCapRené RechtmanInvestor at FELIX CAPITALValerie AelbrechtInvestment Manager at AlbionVCPeter AnderssonPartner, Investor Relations at Adams Street PartnersMaria Henriques da SilvaMarketing & Brand Lead at Shilling VCHelen ClarkPartner at Piton Capital LLP
+ 55 more
Shared employers
Also worked at UCB34
Ben PerryInvestor at MedicxiMary PattonScientific Advisory Board at InnoCom Bio EquitiesMiguel ForteAdvisor at Delin VenturesJohn LeonardExecutives in Residence at GENERAL INCEPTIONSam GrayManaging Partner at Apposite CapitalDavid DevigneInvestment Director at Korys
+ 28 more
